Special aspects of biosimilars as an object of intellectual property

Journal Title: Фармацевтичний журнал - Year 2015, Vol 3, Issue 3

Abstract

Main factors of the development of biosimilars market are their high efficiency, the availability of evidential base, a reasonable price compared to the original products, broad field of application, the social importance and increasing interest in these states and pharmaceutical companies for their production. The aim of the work is analysis of special aspects and main trends in development of patenting of technical solutions for the creation of biosimilars and their pharmacoeconomic evaluation. It has established that biosimilars meet the criteria of patentability are requiremented for inventions: novelty, inventive step, industrial applicability. The main objects of biosimilar patent are pharmaceutical composition, methods of producing the API, new dosage form, the methods of treatment, a new indication for known drugs, and others. Objects of the invention at biosimilar patenting are: increase in the yield of the desired product; simplification of method; reducing the time of the method; increasing purity of the target product; expanding resource base; increase stability, increase or enhancement of pharmacological activity, increased bioavailability, decreased toxicity of the desired product, improved consumer properties and others. It was characterized the strategy of legal protection of biosimilars by foreign applicants, including in Ukraine, Russian Federation, the European Union and United States. It was showed significant pharmacoeconomic benefits of biosimilars by domestic production (cost below 2.5 times) compared to the original drug.

Authors and Affiliations

О. V. Litvinova

Keywords

Related Articles

Analysis of the range of medicines for treatment of acne on the pharmaceutical market of Ukraine

Acne is one of the most common medico-social diseases of the skin and subcutaneous tissue; it significantly affects the psycho-emotional and the social components of the life’s quality of patients. The topical issue of p...

Application of surface in physics methods in pharmaceutical development of the medicine on the basis of essential phospholipids

The main issues addressed in the process of pharmaceutical medicine’s development include the choice of substance, excipients; development of technological and analytical methods of control; definition of critical points...

Dynamics of accessibility of medicines for type 2 diabetes monotherapy in Ukraine

Diabetes mellitus is recognized as noninfectious epidemic in the world. Antidiabetic medications for the patients are taking continually and they are expensive. So, the actual question is the evaluation of the economic a...

Сhronic toxicity testing complex phytopoliextraction of sedative action

Development and introduction in medical practice sedative meals on the base of complex phytopoliextracts from the domestic medical plants permitted for medical application is highly actual because of incrised incidence o...

Development of the technology of cream for diabetic foot

Diabetes mellitus is one of the most difficult problems of our time. Aggravating factors in the course of the disease are numerous complications that lead to disability and early mortality. One of the most dangerous comp...

Download PDF file
  • EP ID EP586452
  • DOI -
  • Views 70
  • Downloads 0

How To Cite

О. V. Litvinova (2015). Special aspects of biosimilars as an object of intellectual property. Фармацевтичний журнал, 3(3), 93-98. https://europub.co.uk/articles/-A-586452